Skip to main content

Closed

COAG: Hemab Therapeutics Holdings, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-37.8%

Financially safe

Stretched

Debt / equity-0.01×

Interest coverage0.0×

Current ratio18.03×

Hemab Therapeutics Holdings, Inc. Common Stock

COAGNASDAQ Global Market·USD·Closed

Hemab Therapeutics Holdings, Inc. Common Stock

COAGNASDAQ·USD·Closed

$47.55

+0.17%

$47.55

+$0.08 (0.17%)

52W Range

84thpctl

Volume

1.19×avg

Mkt Cap

95.52MUSD

P/E

-20.4TTM

Div Yield

–ann

52W Range

84thpctl

Volume

1.19×avg

Market Cap

95.52MUSD

P/E Ratio

-20.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings